You may have seen the news this week about the first documented a case of an individual contracting HIV, a multi-drug resistant strain, while apparently adhering well to the daily regimen of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP).  According to a story published on the “POZ” website on February 25, 2016:
Read more...
Every February, the prevention team at Mazzoni Center observes National Black HIV/AIDS Awareness Day with educational programming, outreach activities and HIV testing at events and in neighborhoods throughout Philadelphia. February 7 has passed but, for people living with HIV, every day brings awareness to the virus and the stigma that still exist.
 
Another day we celebrated in February is Valentine’s Day. For those who are single it can be a day to dread. This holiday can even be harder for those living with HIV, as love, romance and relationships may Read more...
Mazzoni Center LGBT HIV AIDS Philadelphia

I’ll be honest: I have very ambivalent feelings about “awareness days.” 

February 7 is National Black HIV/AIDS Awareness Day.  As an African American who has been working in the HIV prevention field for more than a decade, I’m well aware of this occasion and its significance.

On the one hand, I can absolutely appreciate the importance of marking a specific day each year to recognize the disproportionate impact that HIV is having on African-Americans in the United States, and Read more...

PrEP Truvada Pre Exposure Prophylaxis

It’s been three years since the FDA approved PrEP (Pre-Exposure Prophylaxis) for use by HIV-negative individuals to prevent them from being infected with HIV.  When PrEP as treatment was first introduced, there was a great deal of excitement in the provider community, particularly among those of us who specialize in treating people with HIV and those at higher risk of contracting it.  In its original clinical trials PrEP showed remarkable efficacy as a prevention tool.

Earlier this fall researchers at Kaiser Permanente Medical Center in San Francisco released what I Read more...

  •